Table 2.
Characteristics of patients taking part in the field test in each of the non-European countries
| Australia n=10 | Canada n=10 | China n=10 | Colombia n=10 | Egypt n=10 | Korea n=10 | Mexico n=10 | Thailand n=10 | USA n=10 | |
|---|---|---|---|---|---|---|---|---|---|
| Age (years), mean (SD) | 43.5 (19.8) | 45.9 (13.4) | 27.8 (12.2) | 45.9 (8.8) | 37.3 (14.7) | 34.8 (11.0) | 36.8 (9.4) | 42.8 (12.6) | 51.6 (12.5) |
| Gender, male (%) | 80 | 60 | 100 | 50 | 60 | 90 | 60 | 50 | 70 |
| Disease subtype, AS (%) | 60 | 80 | 60 | 60 | 50 | 60 | 60 | 100 | 80 |
| Disease duration (years), mean (SD) | 21.9 (7.6) | 11.9 (13.5) | 2.7 (4.5) | 5.7 (4.2) | 9.3 (7.7) | 3.0 (1.8) | 12.9 (8.9) | 9.5 (6.9) | 18.3 (19.1) |
| Working status, paid work (%) | 60 | 70 | 40 | 60 | 90 | 30 | 90 | 60 | 30 |
| Education (years), mean (SD) | 13.5 (3.7) | 13.9 (1.7) | 14.2 (8.5) | 13.8 (2.1) | 14.9 (4.0) | 11.7 (3.6) | 13.3 (5.5) | 13.1 (4.5) | 15.8 (3.7) |
| ASAS HI, mean (SD) | 5.7 (2.7) | 8.2 (4.3) | 6.1 (5.0) | 12.6 (2.7) | 6.0 (3.6) | 7.4 (5.1) | 9.2 (3.9) | 6.5 (4.7) | 8.4 (4.2) |
| ASAS HI, range | 2–10 | 0–16 | 0–15 | 7–16 | 0–11 | 0–14 | 3–15 | 1–14 | 2–15 |
| BASDAI, mean (SD) | 3.4 (2.3) | 4.5 (2.8) | 3.0 (2.4) | 5.9 (2.0) | 3.9 (2.3) | 3.5 (2.0) | 4.0 (1.9) | 3.2 (1.9) | 5.3 (2.2) |
| BASDAI, range | 2–10 | 1.2–8.7 | 0.2–7.0 | 1.8–8.4 | 1.2–8.1 | 0.4–7.4 | 0.2–6.6 | 0.6–6.3 | 0.7–8.4 |
AS, ankylosing spondylitis; ASAS HI, ASAS Health Index; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index.